Sudarshan Pharma to Acquire 9.50% Stake in Med Therapy Biotechnology

Sudarshan Pharma Industries Ltd has announced a proposal to acquire a 9.50% equity stake in Med Therapy Biotechnology Inc., USA. This announcement follows previous communications on September 5, 2026, and September 15, 2026, regarding the same transaction. The filing references the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2015, indicating compliance with regulatory requirements for such acquisitions. Further details on the financial implications and strategic rationale are expected.